Revenue: The sum of all revenue fields included for a company's operating activities.
Verrica Pharmaceuticals Inc. (VRCA) had Revenue of $6.91M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$6.91M |
$-12.41M |
|
$1.15M |
|
$5.77M |
|
$19.08M |
|
$-12.17M |
|
$-0.24M |
|
$-12.41M |
|
$-12.41M |
|
$-12.41M |
|
$-12.41M |
|
$-12.41M |
|
$-12.41M |
|
$-12.17M |
|
$-11.96M |
|
21.30M |
|
21.30M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$36.40M |
|
$0.17M |
|
$3.46M |
|
$39.86M |
|
$21.93M |
|
$12.41M |
|
$23.91M |
|
$45.84M |
|
$-5.97M |
|
$-5.97M |
|
$-5.97M |
|
17.18M |
|
| Cash Flow Statement Financials | |
$-27.48M |
|
-- |
|
$11.99M |
|
$30.15M |
|
$14.66M |
|
$-15.49M |
|
$4.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.66 |
|
-- |
|
-- |
|
1.93 |
|
-2.17 |
|
83.40% |
|
-175.98% |
|
-175.98% |
|
-- |
|
-179.45% |
|
-179.45% |
|
$-27.48M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.41 |
|
0.59 |
|
151.64 |
|
207.68% |
|
207.68% |
|
-31.13% |
|
-192.81% |
|
$-0.35 |
|
$-1.29 |
|
$-1.29 |
|